Kinnaman, M. D., Hamill, D., Yabe, M., Powell, J., Benhamida, J., Hasselblatt, M., . . . Shukla, N. (2020). Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1. JCO precision oncology, 4, . https://doi.org/10.1200/PO.20.00215
Chicago-Zitierstil (17. Ausg.)Kinnaman, Michael D., et al. "Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1." JCO Precision Oncology 4 (2020). https://doi.org/10.1200/PO.20.00215.
MLA-Zitierstil (9. Ausg.)Kinnaman, Michael D., et al. "Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1." JCO Precision Oncology, vol. 4, 2020, https://doi.org/10.1200/PO.20.00215.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.